16例肺隔离症的介入治疗分析  

Interventional therapy for pulmonary sequestration: a clinical analysis on 16 cases

作　　者：李林[1] 杨炼 刘德翰 张炜[1] 吴欣[1] 郑传胜[1] LI Lin;YANG Lian;LIU De-han;ZHANG Wei;WU Xin;ZHENG Chuan-sheng(Department of Radiology,Union Hospital,Tongji Medical College of Huazhong University of Science and Technology,Wuhan 430056,China)

机构地区：[1]华中科技大学同济医学院附属协和医院放射科,湖北武汉430056

出　　处：《中国临床医学影像杂志》2020年第7期482-485,共4页Journal of China Clinic Medical Imaging

摘　　要：目的:探讨肺隔离症经动脉栓塞治疗的疗效及安全性。方法:回顾分析2003年9月—2019年6月16例在我院就诊并行介入治疗的肺隔离症的患者的临床资料,根据造影的情况选择不同的栓塞材料行介入栓塞治疗,术后随访2~48月(平均20月)。结果:所有患者均成功行介入栓塞治疗,材料包括弹簧圈及PVA颗粒,随访期间未见咯血复发及严重并发症发生。结论:介入栓塞是治疗肺隔离症安全且有效的方法。Objective: To discuss the efficacy and safety of transarterial embolization(TAE) therapy in patients with pulmonary sequestration. Methods: Clinical data of 16 patients who suffered from pulmonary sequestration and accepted intervention therapy in our hospital from Sep 2003 to Jun 2019 were retrospectively analyzed. All patients underwent angiography and TAE with various embolic materials according to the lesion’s nature, location, extent, etc. They were followed up for 2 to 48 months(mean of 20 months) after the procedure. Results: Embolization was successfully carried out in all of them. The embolic materials included PVA and coils. After a mean follow-up of 20 months, no serious adverse effects were observed in all patients. There were no complaints of hemoptysis at the end of the follow-up period. Conclusion: Transcatheter arterial embolization is a safe and effective treatment for pulmonary sequestration.

关 键 词：支气管肺隔离症 放射学 介入性 

分 类 号：R563[医药卫生—呼吸系统] R815[医药卫生—内科学]